Andras Bikov1,2,3, Martina Meszaros1, Laszlo Kunos1, Alina Gabriela Negru4,5, Stefan Marian Frent6,7, Stefan Mihaicuta6,7. 1. Department of Pulmonology, Semmelweis University, 1085 Budapest, Hungary. 2. North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M239LT, UK. 3. Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester M239LT, UK. 4. Department of Cardiology, University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania. 5. Cardiology Department, Institute of Cardiovascular Diseases Timisoara, 300310 Timisoara, Romania. 6. Department of Pulmonology, University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania. 7. Pulmonology Department, 'Victor Babes' Infectious Diseases and Pulmonology Hospital Timisoara, 300310 Timisoara, Romania.
Abstract
BACKGROUND: Dyslipidaemia is well recognised in obstructive sleep apnoea (OSA) and could contribute to the development of cardiovascular disease (CVD). Atherogenic index of plasma (AIP) predicts cardiovascular morbidity and mortality better than the individual lipid levels. The aim of this study was to investigate the AIP in patients with OSA in relation with disease severity. METHODS: Four hundred sixty-one patients with OSA and 99 controls participated in this study. AIP was assessed in the morning following a diagnostic sleep study. The association between lipid values and OSA were adjusted for age, gender, and body mass index. RESULTS: Patients with OSA had higher AIP and triglyceride, and lower high-density lipoprotein cholesterol (HDL-C) levels (all p < 0.05). AIP significantly correlated with the Epworth Sleepiness Scale score (ρ = 0.19), the apnoea-hypopnoea index (ρ = 0.40) and oxygen desaturation index (ρ = 0.43, all p < 0.05). However, there was no relationship between the AIP and markers of sleep quality such as total sleep time, sleep period time, sleep efficiency, arousal index or percentage of REM sleep (all p > 0.05). AIP was not a better predictor for self-reported cardiovascular disease or diabetes than HDL-C. CONCLUSIONS: AIP is elevated in OSA and is related to disease severity. However, it does not seem to have an additional clinical value compared to HDL-C.
BACKGROUND: Dyslipidaemia is well recognised in obstructive sleep apnoea (OSA) and could contribute to the development of cardiovascular disease (CVD). Atherogenic index of plasma (AIP) predicts cardiovascular morbidity and mortality better than the individual lipid levels. The aim of this study was to investigate the AIP in patients with OSA in relation with disease severity. METHODS: Four hundred sixty-one patients with OSA and 99 controls participated in this study. AIP was assessed in the morning following a diagnostic sleep study. The association between lipid values and OSA were adjusted for age, gender, and body mass index. RESULTS:Patients with OSA had higher AIP and triglyceride, and lower high-density lipoprotein cholesterol (HDL-C) levels (all p < 0.05). AIP significantly correlated with the Epworth Sleepiness Scale score (ρ = 0.19), the apnoea-hypopnoea index (ρ = 0.40) and oxygen desaturation index (ρ = 0.43, all p < 0.05). However, there was no relationship between the AIP and markers of sleep quality such as total sleep time, sleep period time, sleep efficiency, arousal index or percentage of REM sleep (all p > 0.05). AIP was not a better predictor for self-reported cardiovascular disease or diabetes than HDL-C. CONCLUSIONS: AIP is elevated in OSA and is related to disease severity. However, it does not seem to have an additional clinical value compared to HDL-C.
Entities:
Keywords:
atherogenic index of plasma; cardiovascular disease; dyslipidemia; sleep apnea
Authors: Jonathan C Jun; Mi-Kyung Shin; Qiaoling Yao; Shannon Bevans-Fonti; James Poole; Luciano F Drager; Vsevolod Y Polotsky Journal: Am J Physiol Endocrinol Metab Date: 2012-05-22 Impact factor: 4.310
Authors: Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi Journal: J Clin Sleep Med Date: 2012-10-15 Impact factor: 4.062
Authors: Michel P Hermans; Yovan P Mahadeb; Philippe Katchunga; Justin Cikomola Cirhuza; Sylvie A Ahn; Michel F Rousseau Journal: Diabetes Metab Syndr Date: 2013-09-10
Authors: François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund Journal: Eur Heart J Date: 2020-01-01 Impact factor: 29.983
Authors: Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg Journal: Eur Heart J Date: 2020-06-21 Impact factor: 29.983
Authors: Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois Journal: Eur Heart J Date: 2016-04-26 Impact factor: 29.983
Authors: Andras Bikov; Stefan M Frent; Martina Meszaros; Laszlo Kunos; Alexander G Mathioudakis; Alina Gabriela Negru; Laura Gaita; Stefan Mihaicuta Journal: J Clin Med Date: 2021-04-29 Impact factor: 4.241
Authors: Branislav Kollar; Pavel Siarnik; Alzbeta Hluchanova; Katarina Klobucnikova; Imrich Mucska; Peter Turcani; Zuzana Paduchova; Barbora Katrencikova; Maria Janubova; Katarina Konarikova; Lubica Argalasova; Stanislav Oravec; Ingrid Zitnanova Journal: Lipids Health Dis Date: 2021-12-05 Impact factor: 3.876